PRF Technologies (PRFX) Other Non-Current Liabilities (2020 - 2025)
PRF Technologies' (PRFX) quarterly Other Non-Current Liabilities came in at $267000.0 in Q4 2025, up 3.09% YoY from $259000.0 in Q4 2024, and up 1.52% on a QoQ basis from $263000.0 in Q2 2025.
PRF Technologies (PRFX) Other Non-Current Liabilities (2020 - 2025) Analysis & Trends
PRF Technologies (PRFX) has 6 years of Other Non-Current Liabilities data on file, last reported at $267000.0 in Q4 2025.
- Quarterly Other Non-Current Liabilities rose 3.09% year-over-year to $267000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $267000.0 (up 3.09% YoY) and the FY2025 annual result came in at $267000.0, up 3.09% from the prior year.
- Other Non-Current Liabilities rose to $267000.0 in Q4 2025, from $263000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $267000.0 in Q4 2025 to a low of $220000.0 in Q2 2021.
- A 5-year average of $247700.0 and a median of $249000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2021 — Other Non-Current Liabilities sank 85.45% — and 2022, when it gained 8.18%.
- Tracing PRFX's Other Non-Current Liabilities over 5 years: stood at $234000.0 in 2021, then advanced by 3.85% to $243000.0 in 2022, then advanced by 3.29% to $251000.0 in 2023, then increased by 3.19% to $259000.0 in 2024, then gained by 3.09% to $267000.0 in 2025.
- The last three Other Non-Current Liabilities figures came in at $267000.0 (Q4 2025), $263000.0 (Q2 2025), and $259000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | PRF Technologies | 647,973.00 | -3.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 267,000.00 |
| Jun 30, 2025 | 263,000.00 |
| Dec 31, 2024 | 259,000.00 |
| Jun 30, 2024 | 255,000.00 |
| Dec 31, 2023 | 251,000.00 |
| Jun 30, 2023 | 247,000.00 |
| Dec 31, 2022 | 243,000.00 |
| Jun 30, 2022 | 238,000.00 |
| Dec 31, 2021 | 234,000.00 |
| Jun 30, 2021 | 220,000.00 |
| Dec 31, 2020 | 220,000.00 |
| Sep 30, 2020 | 1.07 Mn |
| Jun 30, 2020 | 1.51 Mn |
| Mar 31, 2020 | 802,000.00 |